Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion type Assertion NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_head.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion description "[For lupus anticoagulant (LA) testing, participant laboratories used a panel of tests, including activated partial thromboplastin time (aPTT; 100% of laboratories), kaolin clotting time (26 to 70%), and Russell's viper venom time (RVVT; 75 to 100%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_provenance.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion evidence source_evidence_literature NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_provenance.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion SIO_000772 15706475 NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_provenance.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion wasDerivedFrom befree-20140225 NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_provenance.
- NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_assertion wasGeneratedBy ECO_0000203 NP862252.RA1eZd1DKXdrL-f5-DVrZP4xWhheqGPhB9iHgsbV18O74130_provenance.